Loading…

Contribution of laser microdissection-based technology to proteomic analysis in hepatocellular carcinoma developing on cirrhosis

Hepatocellular carcinoma (HCC) is a major cause of cancer worldwide. Proteomic studies provide opportunities to uncover targets for the diagnosis and treatment of this disease. However, in HCC developing in a setting of cirrhosis, the detection of proteome alterations may be hampered by the increase...

Full description

Saved in:
Bibliographic Details
Published in:Proteomics. Clinical applications 2007-06, Vol.1 (6), p.545-554
Main Authors: Dos Santos, Alexandre, Thiers, Valérie, Sar, Sokhavuth, Derian, Nicolas, Bensalem, Noura, Yilmaz, Funda, Bralet, Marie-Pierre, Ducot, Béatrice, Bréchot, Christian, Demaugre, France
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5454-bdacf8645db844633c5380c517b506d0b2c06f0a80b069bcffde30958756c00c3
cites cdi_FETCH-LOGICAL-c5454-bdacf8645db844633c5380c517b506d0b2c06f0a80b069bcffde30958756c00c3
container_end_page 554
container_issue 6
container_start_page 545
container_title Proteomics. Clinical applications
container_volume 1
creator Dos Santos, Alexandre
Thiers, Valérie
Sar, Sokhavuth
Derian, Nicolas
Bensalem, Noura
Yilmaz, Funda
Bralet, Marie-Pierre
Ducot, Béatrice
Bréchot, Christian
Demaugre, France
description Hepatocellular carcinoma (HCC) is a major cause of cancer worldwide. Proteomic studies provide opportunities to uncover targets for the diagnosis and treatment of this disease. However, in HCC developing in a setting of cirrhosis, the detection of proteome alterations may be hampered by the increased cellular heterogeneity of tissue when analysing global liver homogenates. The aim of this study was to evaluate whether the identification of proteome alterations in these HCC cases was improved when the differential protein profile between tumour and non‐tumour areas of liver was determined using hepatocytes isolated by laser microdissection (LM). Differential profiles established with LM‐hepatocytes and liver section homogenates using 2‐DE and MS exhibited noticeable differences: 30% of the protein spots with deregulated expression in tumorous LM‐samples did not display any modification in homogenates; conversely 15% of proteins altered in tumorous homogenates were not impaired in LM‐hepatocytes. These alterations resulted from the presence in cirrhotic liver of fibrotic stroma which displayed a protein pattern different from that determined in LM‐hepatocytes. In conclusion, our data demonstrate the interest of LM in distinguishing between fibrotic and hepatocyte proteome alterations and thus the benefit of LM to proteome studies of HCC developing in a context of cirrhosis.
doi_str_mv 10.1002/prca.200600474
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3035364</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>816529134</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5454-bdacf8645db844633c5380c517b506d0b2c06f0a80b069bcffde30958756c00c3</originalsourceid><addsrcrecordid>eNqFkktv1DAUhSMEoqWwZYm8ohsyXMePZDZIo4G2qMNDiNfOchxnxpDYwU6Gzq4_HUcpUWEBK1u-3znX95EkjzEsMED2vPNKLjIADkBzeic5xgXP0oIwene-U36UPAjhGwCjWQ73k6MMY8JzYMfJ9drZ3pty6I2zyNWokUF71BrlXWVC0GoMpGV8rVCv1c66xm0PqHeo867XLpJIWtkcggnIWLTTneyd0k0zNNIjJb0y1rUSVXqvG9cZu0UxkzLe71zUPEzu1bIJ-tHNeZJ8Onv1cX2Rbt6dv16vNqlilNG0rKSqC05ZVRaUckIUIwUohvOSAa-gzBTwGmQBJfBlqeq60gSWrMgZVwCKnCQvJt9uKFtdKR3Llo3ovGmlPwgnjfgzYs1ObN1eECCMcBoNnk0Gu79kF6uNMDZ2rRXjEPI8Y3sc8dObfN79GHToRWvC2BZptRuCKDBn2RKT0fjpP8kMKOYZJhFcTGCcTQhe1_M3MIhxG8S4DWLehih4crvmGf89_ggsJ-CnafThP3bi_Yf16rZ5OmlN6PXVrJX-u-A5yZn48vZc0M8vv569oZfikvwChdLUpw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20416213</pqid></control><display><type>article</type><title>Contribution of laser microdissection-based technology to proteomic analysis in hepatocellular carcinoma developing on cirrhosis</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Dos Santos, Alexandre ; Thiers, Valérie ; Sar, Sokhavuth ; Derian, Nicolas ; Bensalem, Noura ; Yilmaz, Funda ; Bralet, Marie-Pierre ; Ducot, Béatrice ; Bréchot, Christian ; Demaugre, France</creator><creatorcontrib>Dos Santos, Alexandre ; Thiers, Valérie ; Sar, Sokhavuth ; Derian, Nicolas ; Bensalem, Noura ; Yilmaz, Funda ; Bralet, Marie-Pierre ; Ducot, Béatrice ; Bréchot, Christian ; Demaugre, France</creatorcontrib><description>Hepatocellular carcinoma (HCC) is a major cause of cancer worldwide. Proteomic studies provide opportunities to uncover targets for the diagnosis and treatment of this disease. However, in HCC developing in a setting of cirrhosis, the detection of proteome alterations may be hampered by the increased cellular heterogeneity of tissue when analysing global liver homogenates. The aim of this study was to evaluate whether the identification of proteome alterations in these HCC cases was improved when the differential protein profile between tumour and non‐tumour areas of liver was determined using hepatocytes isolated by laser microdissection (LM). Differential profiles established with LM‐hepatocytes and liver section homogenates using 2‐DE and MS exhibited noticeable differences: 30% of the protein spots with deregulated expression in tumorous LM‐samples did not display any modification in homogenates; conversely 15% of proteins altered in tumorous homogenates were not impaired in LM‐hepatocytes. These alterations resulted from the presence in cirrhotic liver of fibrotic stroma which displayed a protein pattern different from that determined in LM‐hepatocytes. In conclusion, our data demonstrate the interest of LM in distinguishing between fibrotic and hepatocyte proteome alterations and thus the benefit of LM to proteome studies of HCC developing in a context of cirrhosis.</description><identifier>ISSN: 1862-8346</identifier><identifier>EISSN: 1862-8354</identifier><identifier>DOI: 10.1002/prca.200600474</identifier><identifier>PMID: 21136705</identifier><language>eng</language><publisher>Weinheim: WILEY-VCH Verlag</publisher><subject>Cirrhosis ; Hepatitis C virus ; Hepatocellular carcinoma ; Human health and pathology ; Hépatology and Gastroenterology ; Laser microdissection ; Life Sciences</subject><ispartof>Proteomics. Clinical applications, 2007-06, Vol.1 (6), p.545-554</ispartof><rights>Copyright © 2007 WILEY‐VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><rights>Copyright © 2007 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5454-bdacf8645db844633c5380c517b506d0b2c06f0a80b069bcffde30958756c00c3</citedby><cites>FETCH-LOGICAL-c5454-bdacf8645db844633c5380c517b506d0b2c06f0a80b069bcffde30958756c00c3</cites><orcidid>0000-0001-9683-5843</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21136705$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://inserm.hal.science/inserm-00477725$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Dos Santos, Alexandre</creatorcontrib><creatorcontrib>Thiers, Valérie</creatorcontrib><creatorcontrib>Sar, Sokhavuth</creatorcontrib><creatorcontrib>Derian, Nicolas</creatorcontrib><creatorcontrib>Bensalem, Noura</creatorcontrib><creatorcontrib>Yilmaz, Funda</creatorcontrib><creatorcontrib>Bralet, Marie-Pierre</creatorcontrib><creatorcontrib>Ducot, Béatrice</creatorcontrib><creatorcontrib>Bréchot, Christian</creatorcontrib><creatorcontrib>Demaugre, France</creatorcontrib><title>Contribution of laser microdissection-based technology to proteomic analysis in hepatocellular carcinoma developing on cirrhosis</title><title>Proteomics. Clinical applications</title><addtitle>Prot. Clin. Appl</addtitle><description>Hepatocellular carcinoma (HCC) is a major cause of cancer worldwide. Proteomic studies provide opportunities to uncover targets for the diagnosis and treatment of this disease. However, in HCC developing in a setting of cirrhosis, the detection of proteome alterations may be hampered by the increased cellular heterogeneity of tissue when analysing global liver homogenates. The aim of this study was to evaluate whether the identification of proteome alterations in these HCC cases was improved when the differential protein profile between tumour and non‐tumour areas of liver was determined using hepatocytes isolated by laser microdissection (LM). Differential profiles established with LM‐hepatocytes and liver section homogenates using 2‐DE and MS exhibited noticeable differences: 30% of the protein spots with deregulated expression in tumorous LM‐samples did not display any modification in homogenates; conversely 15% of proteins altered in tumorous homogenates were not impaired in LM‐hepatocytes. These alterations resulted from the presence in cirrhotic liver of fibrotic stroma which displayed a protein pattern different from that determined in LM‐hepatocytes. In conclusion, our data demonstrate the interest of LM in distinguishing between fibrotic and hepatocyte proteome alterations and thus the benefit of LM to proteome studies of HCC developing in a context of cirrhosis.</description><subject>Cirrhosis</subject><subject>Hepatitis C virus</subject><subject>Hepatocellular carcinoma</subject><subject>Human health and pathology</subject><subject>Hépatology and Gastroenterology</subject><subject>Laser microdissection</subject><subject>Life Sciences</subject><issn>1862-8346</issn><issn>1862-8354</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkktv1DAUhSMEoqWwZYm8ohsyXMePZDZIo4G2qMNDiNfOchxnxpDYwU6Gzq4_HUcpUWEBK1u-3znX95EkjzEsMED2vPNKLjIADkBzeic5xgXP0oIwene-U36UPAjhGwCjWQ73k6MMY8JzYMfJ9drZ3pty6I2zyNWokUF71BrlXWVC0GoMpGV8rVCv1c66xm0PqHeo867XLpJIWtkcggnIWLTTneyd0k0zNNIjJb0y1rUSVXqvG9cZu0UxkzLe71zUPEzu1bIJ-tHNeZJ8Onv1cX2Rbt6dv16vNqlilNG0rKSqC05ZVRaUckIUIwUohvOSAa-gzBTwGmQBJfBlqeq60gSWrMgZVwCKnCQvJt9uKFtdKR3Llo3ovGmlPwgnjfgzYs1ObN1eECCMcBoNnk0Gu79kF6uNMDZ2rRXjEPI8Y3sc8dObfN79GHToRWvC2BZptRuCKDBn2RKT0fjpP8kMKOYZJhFcTGCcTQhe1_M3MIhxG8S4DWLehih4crvmGf89_ggsJ-CnafThP3bi_Yf16rZ5OmlN6PXVrJX-u-A5yZn48vZc0M8vv569oZfikvwChdLUpw</recordid><startdate>20070601</startdate><enddate>20070601</enddate><creator>Dos Santos, Alexandre</creator><creator>Thiers, Valérie</creator><creator>Sar, Sokhavuth</creator><creator>Derian, Nicolas</creator><creator>Bensalem, Noura</creator><creator>Yilmaz, Funda</creator><creator>Bralet, Marie-Pierre</creator><creator>Ducot, Béatrice</creator><creator>Bréchot, Christian</creator><creator>Demaugre, France</creator><general>WILEY-VCH Verlag</general><general>WILEY‐VCH Verlag</general><general>Wiley-VCH Verlag</general><general>Wiley-VCH</general><scope>BSCLL</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9683-5843</orcidid></search><sort><creationdate>20070601</creationdate><title>Contribution of laser microdissection-based technology to proteomic analysis in hepatocellular carcinoma developing on cirrhosis</title><author>Dos Santos, Alexandre ; Thiers, Valérie ; Sar, Sokhavuth ; Derian, Nicolas ; Bensalem, Noura ; Yilmaz, Funda ; Bralet, Marie-Pierre ; Ducot, Béatrice ; Bréchot, Christian ; Demaugre, France</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5454-bdacf8645db844633c5380c517b506d0b2c06f0a80b069bcffde30958756c00c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Cirrhosis</topic><topic>Hepatitis C virus</topic><topic>Hepatocellular carcinoma</topic><topic>Human health and pathology</topic><topic>Hépatology and Gastroenterology</topic><topic>Laser microdissection</topic><topic>Life Sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dos Santos, Alexandre</creatorcontrib><creatorcontrib>Thiers, Valérie</creatorcontrib><creatorcontrib>Sar, Sokhavuth</creatorcontrib><creatorcontrib>Derian, Nicolas</creatorcontrib><creatorcontrib>Bensalem, Noura</creatorcontrib><creatorcontrib>Yilmaz, Funda</creatorcontrib><creatorcontrib>Bralet, Marie-Pierre</creatorcontrib><creatorcontrib>Ducot, Béatrice</creatorcontrib><creatorcontrib>Bréchot, Christian</creatorcontrib><creatorcontrib>Demaugre, France</creatorcontrib><collection>Istex</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proteomics. Clinical applications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dos Santos, Alexandre</au><au>Thiers, Valérie</au><au>Sar, Sokhavuth</au><au>Derian, Nicolas</au><au>Bensalem, Noura</au><au>Yilmaz, Funda</au><au>Bralet, Marie-Pierre</au><au>Ducot, Béatrice</au><au>Bréchot, Christian</au><au>Demaugre, France</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Contribution of laser microdissection-based technology to proteomic analysis in hepatocellular carcinoma developing on cirrhosis</atitle><jtitle>Proteomics. Clinical applications</jtitle><addtitle>Prot. Clin. Appl</addtitle><date>2007-06-01</date><risdate>2007</risdate><volume>1</volume><issue>6</issue><spage>545</spage><epage>554</epage><pages>545-554</pages><issn>1862-8346</issn><eissn>1862-8354</eissn><abstract>Hepatocellular carcinoma (HCC) is a major cause of cancer worldwide. Proteomic studies provide opportunities to uncover targets for the diagnosis and treatment of this disease. However, in HCC developing in a setting of cirrhosis, the detection of proteome alterations may be hampered by the increased cellular heterogeneity of tissue when analysing global liver homogenates. The aim of this study was to evaluate whether the identification of proteome alterations in these HCC cases was improved when the differential protein profile between tumour and non‐tumour areas of liver was determined using hepatocytes isolated by laser microdissection (LM). Differential profiles established with LM‐hepatocytes and liver section homogenates using 2‐DE and MS exhibited noticeable differences: 30% of the protein spots with deregulated expression in tumorous LM‐samples did not display any modification in homogenates; conversely 15% of proteins altered in tumorous homogenates were not impaired in LM‐hepatocytes. These alterations resulted from the presence in cirrhotic liver of fibrotic stroma which displayed a protein pattern different from that determined in LM‐hepatocytes. In conclusion, our data demonstrate the interest of LM in distinguishing between fibrotic and hepatocyte proteome alterations and thus the benefit of LM to proteome studies of HCC developing in a context of cirrhosis.</abstract><cop>Weinheim</cop><pub>WILEY-VCH Verlag</pub><pmid>21136705</pmid><doi>10.1002/prca.200600474</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-9683-5843</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1862-8346
ispartof Proteomics. Clinical applications, 2007-06, Vol.1 (6), p.545-554
issn 1862-8346
1862-8354
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3035364
source Wiley-Blackwell Read & Publish Collection
subjects Cirrhosis
Hepatitis C virus
Hepatocellular carcinoma
Human health and pathology
Hépatology and Gastroenterology
Laser microdissection
Life Sciences
title Contribution of laser microdissection-based technology to proteomic analysis in hepatocellular carcinoma developing on cirrhosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T17%3A35%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Contribution%20of%20laser%20microdissection-based%20technology%20to%20proteomic%20analysis%20in%20hepatocellular%20carcinoma%20developing%20on%20cirrhosis&rft.jtitle=Proteomics.%20Clinical%20applications&rft.au=Dos%20Santos,%20Alexandre&rft.date=2007-06-01&rft.volume=1&rft.issue=6&rft.spage=545&rft.epage=554&rft.pages=545-554&rft.issn=1862-8346&rft.eissn=1862-8354&rft_id=info:doi/10.1002/prca.200600474&rft_dat=%3Cproquest_pubme%3E816529134%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5454-bdacf8645db844633c5380c517b506d0b2c06f0a80b069bcffde30958756c00c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20416213&rft_id=info:pmid/21136705&rfr_iscdi=true